Onyx Scientific has announced an investment of more than £1.5m to expand its Good Manufacturing Practice (GMP) facilities, and increase capacity for commercial active pharmaceutical ingredient (API) production at the company’s Sunderland UK facility.
Bracco Imaging, a pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, has announced the expansion of its BubbleGen cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit.
Alfa Laval is calling upon pharma manufacturers to unlock new efficiencies and resilience by prioritising proactive heat exchanger maintenance, as detailed in its new report, Ask the HEXperts.
Phesi has launched a new Protocol Complexity analysis module within its AI-powered Trial Accelerator platform that lets sponsors identify and reduce protocol complexity before it drives up cost, timelines and execution risk.
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8th October), and demonstrate how they solve diverse drug delivery challenges.
At CPHI Milan, GEA launches a new approach to coating technology that removes the guesswork from formulation development and bridges the gap between R&D and commercial-scale OSD manufacturing.
Prabhakar Reddy, PhD, senior director, Pharmaceutical Science General Chapters & Complex Generics, USP discusses how complex formulations demand a new approach to quality and standardisation.
A European consortium has demonstrated a new way of manufacturing pharmaceutical ingredients that could help reduce dependence on centralised production, strengthen medicine supply chains and accelerate the industrialisation of critical drugs.
